Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Shionogi & Co ( (JP:4507) ) has issued an update.
Shionogi & Co., Ltd. announced the successful acquisition of TORII PHARMACEUTICAL CO., LTD., making it a wholly-owned subsidiary. This strategic move, completed through a series of transactions including a tender offer and stock consolidation, positions Shionogi to strengthen its market presence and operational capabilities in the pharmaceutical sector.
The most recent analyst rating on (JP:4507) stock is a Buy with a Yen2919.00 price target. To see the full list of analyst forecasts on Shionogi & Co stock, see the JP:4507 Stock Forecast page.
More about Shionogi & Co
Shionogi & Co., Ltd. is a pharmaceutical company based in Osaka, Japan, specializing in the manufacture and sale of pharmaceutical products. The company focuses on developing innovative treatments and has a significant presence in the pharmaceutical industry.
YTD Price Performance: 16.36%
Average Trading Volume: 2,269,647
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen2242.8B
See more insights into 4507 stock on TipRanks’ Stock Analysis page.